Suspect hepatitis vaccines sealed for investigation
Print Edition
The hepatitis B vaccines suspected of causing the death of two babies have been sealed for investigation, a manager of the company that produces them said.
The vaccines were produced by Biokangtai in Shenzhen, Guangdong Province.
The company produced 450,000 hepatitis B vaccines last year and the suspect ones came from two different batches, Southern Metropolis Daily reported, citing a Biokangtai manager.
The manager told the newspaper the bulk of the vaccines were sold to Hunan Province, where two babies have died after receiving a vaccination.
However, 3,600 vaccines were sold to Guangdong Province and some to Guizhou Province, the manager added.
In Guangdong, 190 vaccines had been used on infants in the city’s capital city of Guangzhou as of Saturday. Authorities there had not received any reports of sickness or deaths, the report said.
No suspect vaccines were sold to Shanghai.
The company was cited as saying the vaccines had not expired and there were no problems during production, storage or transportation.
Both the China Food and Drug Administration and Shenzhen’s drug watchdog were still investigating.
Vaccinations have been a key part of a successful national strategy to combat hepatitis in China, a practice that has been encouraged by the World Health Organization.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
